Celator Pharmaceuticals, Inc. Announces Business Update And Fourth Quarter And Full Year 2013 Financial Results
3/25/2014 9:05:25 AM
EWING, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by